AML Relapse (MDT)
Expert advisory panel meeting for specialist input for patients with relapsed/ refractory and high risk AML. This includes those with MRD (measurable residual disease) relapse. Coming soon in 2026.
Expert advisory panel meeting for specialist input for patients with relapsed/ refractory and high risk AML. This includes those with MRD (measurable residual disease) relapse. Coming soon in 2026.
